DP VI Associates, L.P.
Insider CIK 1298034 · ALIM 10% owner · MRNS 10% owner · OCRX 10% owner · RGDO 10% owner · CADX 10% owner · ALDX 10% owner · CLCD Director, 10% owner · SNDX Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OCRX Ocera Therapeutics, Inc. | D To issuer | 2017-12-11 | 2017-12-13 | 15,731 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | U Tender | 2016-11-01 | 2016-11-03 | 1,657 | $28.35 | $47.0K | 0 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | S Sale | 2016-08-03 | 2016-08-03 | 129 | $8.15 | $1.1K | 3,039 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | S Sale | 2016-08-02 | 2016-08-03 | 32 | $8.71 | $279 | 3,168 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | S Sale | 2016-08-01 | 2016-08-03 | 84 | $8.82 | $741 | 3,200 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | S Sale | 2016-04-28 | 2016-05-02 | 235 | $6.96 | $1.6K | 3,284 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | C Conversion deriv | 2016-03-08 | 2016-03-08 | 13,925 | — | $0 | 0 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | C Conversion | 2016-03-08 | 2016-03-08 | 13,925 | — | $0 | 13,925 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | C Conversion deriv | 2015-05-11 | 2015-05-11 | 1,954 | — | $0 | 0 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | C Conversion deriv | 2015-05-11 | 2015-05-11 | 1,565 | — | $0 | 0 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | C Conversion | 2015-05-11 | 2015-05-11 | 3,519 | — | $0 | 3,519 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 8,792 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 1,165 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 7,043 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion | 2014-08-05 | 2014-08-07 | 17,000 | — | $0 | 17,000 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | C Conversion deriv | 2014-05-01 | 2014-05-05 | 3,882 | — | $0 | 0 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | C Conversion | 2014-05-01 | 2014-05-05 | 9,208 | — | $0 | 9,208 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer | 2014-03-19 | 2014-03-21 | 78,369 | $14.00 | $1.10M | 0 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2014-01-16 | 2014-01-17 | 2,230 | $6.56 | $14.6K | 34,907 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2014-01-15 | 2014-01-17 | 1,010 | $6.01 | $6.1K | 37,137 | SEC↗ |
| RGDO Regado Biosciences Inc | C Conversion deriv | 2013-08-27 | 2013-08-28 | 7,407 | — | $0 | 0 | SEC↗ |
| RGDO Regado Biosciences Inc | C Conversion deriv | 2013-08-27 | 2013-08-28 | 2,899 | — | $0 | 0 | SEC↗ |
| RGDO Regado Biosciences Inc | C Conversion deriv | 2013-08-27 | 2013-08-28 | 4,233 | — | $0 | 0 | SEC↗ |
| RGDO Regado Biosciences Inc | C Conversion | 2013-08-27 | 2013-08-28 | 2,899 | — | $0 | 7,513 | SEC↗ |
| RGDO Regado Biosciences Inc | C Conversion | 2013-08-27 | 2013-08-28 | 4,233 | — | $0 | 4,614 | SEC↗ |
| RGDO Regado Biosciences Inc | C Conversion | 2013-08-27 | 2013-08-28 | 7,407 | — | $0 | 14,920 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2013-06-20 | 2013-06-24 | 114 | $5.01 | $571 | 38,147 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2013-06-19 | 2013-06-20 | 244 | $5.37 | $1.3K | 38,261 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2013-06-18 | 2013-06-20 | 359 | $5.40 | $1.9K | 38,505 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2013-06-17 | 2013-06-18 | 959 | $5.40 | $5.2K | 38,864 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2013-06-14 | 2013-06-18 | 425 | $5.03 | $2.1K | 39,823 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2013-06-11 | 2013-06-13 | 59 | $5.00 | $295 | 40,248 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2013-05-16 | 2013-05-17 | 232 | $4.50 | $1.0K | 40,307 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | S Sale | 2013-05-15 | 2013-05-17 | 251 | $4.70 | $1.2K | 40,539 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-21 | 2013-03-22 | 1,743 | $5.49 | $9.6K | 78,369 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-20 | 2013-03-21 | 182 | $5.22 | $950 | 80,112 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-19 | 2013-03-21 | 261 | $5.19 | $1.4K | 80,294 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-18 | 2013-03-19 | 265 | $5.16 | $1.4K | 80,555 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-15 | 2013-03-19 | 318 | $5.28 | $1.7K | 80,820 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-14 | 2013-03-15 | 166 | $5.36 | $890 | 81,138 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-13 | 2013-03-15 | 256 | $5.40 | $1.4K | 81,304 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-12 | 2013-03-13 | 210 | $5.38 | $1.1K | 81,560 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-11 | 2013-03-13 | 136 | $5.34 | $726 | 81,770 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-08 | 2013-03-11 | 171 | $5.32 | $910 | 81,906 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-07 | 2013-03-11 | 420 | $5.22 | $2.2K | 82,077 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-06 | 2013-03-07 | 127 | $5.06 | $643 | 82,497 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-05 | 2013-03-07 | 134 | $5.01 | $671 | 82,624 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-04 | 2013-03-05 | 170 | $5.01 | $852 | 82,758 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-03-01 | 2013-03-05 | 253 | $5.01 | $1.3K | 82,928 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-02-20 | 2013-02-22 | 66 | $5.01 | $331 | 83,181 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-02-19 | 2013-02-20 | 334 | $5.02 | $1.7K | 83,247 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-02-15 | 2013-02-20 | 99 | $5.00 | $495 | 83,581 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-02-14 | 2013-02-15 | 98 | $5.01 | $491 | 83,680 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-02-13 | 2013-02-15 | 191 | $5.00 | $955 | 83,778 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-02-01 | 2013-02-05 | 322 | $4.85 | $1.6K | 83,969 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-31 | 2013-02-01 | 613 | $4.71 | $2.9K | 84,291 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-30 | 2013-02-01 | 367 | $5.00 | $1.8K | 84,904 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-29 | 2013-01-30 | 507 | $5.27 | $2.7K | 85,271 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-28 | 2013-01-30 | 551 | $5.40 | $3.0K | 85,778 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-25 | 2013-01-28 | 456 | $5.38 | $2.5K | 86,329 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-24 | 2013-01-28 | 1,201 | $5.45 | $6.5K | 86,785 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-23 | 2013-01-24 | 839 | $5.11 | $4.3K | 87,986 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-22 | 2013-01-24 | 495 | $5.02 | $2.5K | 88,825 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-18 | 2013-01-22 | 631 | $5.19 | $3.3K | 89,320 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-01-17 | 2013-01-22 | 418 | $5.35 | $2.2K | 89,951 | SEC↗ |